Skip to content
Screener

Prestige Consumer Healthcare PBH Cumulative Gross Losses and Impairments

Cumulative Gross Losses and Impairments at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
$7.07B+28.6%

Segments

By segment

See full
North American OTC Healthcare$212.52M0.0%
International OTC Healthcare$1.59M0.0%

Other financials

Income statement

See full
Revenue$265.7M+6.5%
Gross profit$136.2M-3.0%
Operating income$52.5M-26.8%
Net income$29.2M-38.5%
EPS (diluted)$0.61-35.8%

Balance sheet

See full
Cash & equivalents$89.1M-36.1%
Total debt$2.1B+97.4%
Total equity$1.9B+3.3%
Total assets$4.6B+33.1%

Cash flow

See full
Operating cash flow$70.8M-10.4%
CapEx$3.7M+342%
Free cash flow$67.1M-14.2%

Valuation

See full
Market cap$2.6B-17.4%
Enterprise value$4.57B+12.9%
P/E15.1×+0.3×
P/S2.4×-0.5×

Profitability

See full
Gross margin53.5%-2.6pp
Operating margin26.3%-3.8pp
Net margin15.6%-3.4pp
FCF margin21.3%-2.6pp

Returns & leverage

See full
Return on equity9.1%-2.9pp
Debt / equity1.1×+0.5×
Current ratio3.2×-1.2×

Where this comes from

Reported directly by Prestige Consumer Healthcare in its filing.

Tagged under the XBRL concept us-gaap:GoodwillImpairedAccumulatedImpairmentLoss.

The source filing: Prestige Consumer Healthcare’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 6:15 AM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001295947-26-000042
(In thousands) / Balance - March 31, 2026North American OTCHealthcareInternational OTC HealthcareConsolidated
Goodwill$763,503$31,709$795,212
Accumulated impairment loss(212,516)(1,587)(214,103)
Balance - March 31, 2026550,98730,122581,109
Additions (a)65,50465,504
Adjustment related to acquisition (b)5,3465,346
Effects of foreign currency exchange rates(1,227)63(1,164)
Balance - June 30, 2026
Goodwill833,12631,772864,898

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Prestige Consumer Healthcare's cumulative gross losses and impairments?
Prestige Consumer Healthcare (PBH) reported cumulative gross losses and impairments of $214.1M in Q2 2026.
How has Prestige Consumer Healthcare's cumulative gross losses and impairments changed year-over-year?
Prestige Consumer Healthcare's cumulative gross losses and impairments decreased by 0.0% year-over-year, from $214.1M to $214.1M.
What is the long-term trend for Prestige Consumer Healthcare's cumulative gross losses and impairments?
Over 5 years (2021 to 2026), Prestige Consumer Healthcare's cumulative gross losses and impairments has grown at a 5.4% compound annual growth rate (CAGR), from $164.96M to $214.1M.
What does cumulative gross losses and impairments mean?
This metric aggregates all unrealized losses and recognized impairment charges on investment securities that have not yet been realized through a sale. It provides a comprehensive view of the negative valuation adjustments impacting the bank's equity. It is a key indicator of the credit and market risk embedded in the bank's long-term holdings.

Ask your AI about Prestige Consumer Healthcare's cumulative gross losses and impairments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude